Matches in SemOpenAlex for { <https://semopenalex.org/work/W2465087626> ?p ?o ?g. }
- W2465087626 abstract "T-cell acute lymphoblastic leukemia (T-ALL) accounts for 15% of pediatric and 25% of adult ALL. With cure rates of ~80% in children and ~40% in adults, there is an urgent need to identify and understand the signaling pathways in T-ALL in order to develop the first targeted therapies for this cancer. The most prevalent oncogene is NOTCH1, which is mutated in about 60% of patient samples [1]. Normally, Notch is restrained by the heterodimerization domain (HD, Figure 1). Notch becomes activated once it engages ligand. γ-secretase cleaves Notch, thus releasing the intracellular domain of Notch (ICN). ICN binds Rbpj and Maml to activate transcription. ICN has a short half-life as phosphodegron motifs in its PEST domain are recognized by the ubiquitin ligase Fbxw7, which targets it for destruction [2,3]. PEST domain deletions improve ICN stability [4]. Mutations in the HD domain trigger ligand-independent activation [5,6]. Target genes of NOTCH1 that drive leukemia include MYC [7–9], HES1 [10], IGF-1R [11], TRIB2 [12], and IL7R [13]. Notch also activates the PI3K/Akt/mTor pathway [11,14,15].Figure 1Model of oncogenic NOTCH1 signaling in T-ALL. NOTCH1 is normally locked in an “off” state, which blocks S2 cleavage. Mutations that discrupt the integrity of the heterodimerization domain (HD, e.g. L1601P) permit ligand-independent S2 ...Collaborative pathways confer resistance to NOTCH inhibitorsγ-secretase inhibitors (GSIs) block Notch signaling (Figure 1). GSIs are being tested in clinical trials in T-ALL and other NOTCH-driven cancers [16–18]. Initial reports show promising activity. However, resistance is an emerging problem. Approximately two-thirds of human T-ALL cell lines are resistant to GSI [1]. GSI depletes ICN in resistant cells just as it does in sensitive cells [7,15]. Thus, cancers resist GSI by activating collaborating pathways to bypass the effects of NOTCH1 inhibition. We previously showed that NOTCH1 mutations are moderate oncogenes in mouse models [19]. Collaborating oncogenic networks are essential to functionally enhance NOTCH1 signaling to leukemogenic levels. These findings have shifted the field toward identifying pathways that collaborate with the NOTCH pathway." @default.
- W2465087626 created "2016-07-22" @default.
- W2465087626 creator A5039019694 @default.
- W2465087626 creator A5078514042 @default.
- W2465087626 date "2013-01-01" @default.
- W2465087626 modified "2023-09-23" @default.
- W2465087626 title "Collaborating Pathways that Functionally Amplify NOTCH1 Signals in T-Cell Acute Lymphoblastic Leukemia." @default.
- W2465087626 cites W1538085254 @default.
- W2465087626 cites W1977582022 @default.
- W2465087626 cites W1984748997 @default.
- W2465087626 cites W1987821813 @default.
- W2465087626 cites W1990983360 @default.
- W2465087626 cites W1994791278 @default.
- W2465087626 cites W2000589976 @default.
- W2465087626 cites W2006806134 @default.
- W2465087626 cites W2007710816 @default.
- W2465087626 cites W2012538791 @default.
- W2465087626 cites W2013709636 @default.
- W2465087626 cites W2027629788 @default.
- W2465087626 cites W2030892050 @default.
- W2465087626 cites W2033983791 @default.
- W2465087626 cites W2037290810 @default.
- W2465087626 cites W2044724807 @default.
- W2465087626 cites W2049396238 @default.
- W2465087626 cites W2056156818 @default.
- W2465087626 cites W2060605982 @default.
- W2465087626 cites W2060710804 @default.
- W2465087626 cites W2068510450 @default.
- W2465087626 cites W2075291089 @default.
- W2465087626 cites W2075317148 @default.
- W2465087626 cites W2086962237 @default.
- W2465087626 cites W2087111933 @default.
- W2465087626 cites W2088990880 @default.
- W2465087626 cites W2099687001 @default.
- W2465087626 cites W2105186755 @default.
- W2465087626 cites W2106393512 @default.
- W2465087626 cites W2106933841 @default.
- W2465087626 cites W2108822341 @default.
- W2465087626 cites W2113503593 @default.
- W2465087626 cites W2116274406 @default.
- W2465087626 cites W2116823767 @default.
- W2465087626 cites W2116965161 @default.
- W2465087626 cites W2119973905 @default.
- W2465087626 cites W2124573669 @default.
- W2465087626 cites W2126959323 @default.
- W2465087626 cites W2132149459 @default.
- W2465087626 cites W2133306731 @default.
- W2465087626 cites W2135763107 @default.
- W2465087626 cites W2136160100 @default.
- W2465087626 cites W2136640137 @default.
- W2465087626 cites W2143723854 @default.
- W2465087626 cites W2147373929 @default.
- W2465087626 cites W2147810480 @default.
- W2465087626 cites W2153293603 @default.
- W2465087626 cites W2160959653 @default.
- W2465087626 cites W2163965017 @default.
- W2465087626 cites W2165208287 @default.
- W2465087626 cites W2166779556 @default.
- W2465087626 cites W2237420558 @default.
- W2465087626 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4798248" @default.
- W2465087626 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26998506" @default.
- W2465087626 hasPublicationYear "2013" @default.
- W2465087626 type Work @default.
- W2465087626 sameAs 2465087626 @default.
- W2465087626 citedByCount "0" @default.
- W2465087626 crossrefType "journal-article" @default.
- W2465087626 hasAuthorship W2465087626A5039019694 @default.
- W2465087626 hasAuthorship W2465087626A5078514042 @default.
- W2465087626 hasConcept C104317684 @default.
- W2465087626 hasConcept C116227048 @default.
- W2465087626 hasConcept C134459356 @default.
- W2465087626 hasConcept C161879069 @default.
- W2465087626 hasConcept C25602115 @default.
- W2465087626 hasConcept C2778461978 @default.
- W2465087626 hasConcept C2780283210 @default.
- W2465087626 hasConcept C502942594 @default.
- W2465087626 hasConcept C54355233 @default.
- W2465087626 hasConcept C62478195 @default.
- W2465087626 hasConcept C75217442 @default.
- W2465087626 hasConcept C86339819 @default.
- W2465087626 hasConcept C86554907 @default.
- W2465087626 hasConcept C86803240 @default.
- W2465087626 hasConcept C95444343 @default.
- W2465087626 hasConceptScore W2465087626C104317684 @default.
- W2465087626 hasConceptScore W2465087626C116227048 @default.
- W2465087626 hasConceptScore W2465087626C134459356 @default.
- W2465087626 hasConceptScore W2465087626C161879069 @default.
- W2465087626 hasConceptScore W2465087626C25602115 @default.
- W2465087626 hasConceptScore W2465087626C2778461978 @default.
- W2465087626 hasConceptScore W2465087626C2780283210 @default.
- W2465087626 hasConceptScore W2465087626C502942594 @default.
- W2465087626 hasConceptScore W2465087626C54355233 @default.
- W2465087626 hasConceptScore W2465087626C62478195 @default.
- W2465087626 hasConceptScore W2465087626C75217442 @default.
- W2465087626 hasConceptScore W2465087626C86339819 @default.
- W2465087626 hasConceptScore W2465087626C86554907 @default.
- W2465087626 hasConceptScore W2465087626C86803240 @default.
- W2465087626 hasConceptScore W2465087626C95444343 @default.
- W2465087626 hasIssue "1" @default.
- W2465087626 hasLocation W24650876261 @default.